arrow
T

Taishi Hata

osaka general medical center
H指数:36
被引数:4,256

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Complete Resection of a Giant Hypervascular Pelvic Floor Solitary Fibrous Tumor Using Intraoperative Balloon Occlusion and Staged Open Abdomen Management: A Case Report

通过术中球囊阻断和分期开腹管理切除巨大富血管盆底孤立性纤维瘤:病例报告

2026-01-010
PRE
Lecithinized superoxide dismutase prevents oxaliplatin-induced peripheral neuropathy: a double-blind, placebo-controlled, randomized phase II study

卵磷脂化超氧化物歧化酶可预防奥沙利铂诱导的周围神经病变:一项双盲、安慰剂对照、随机II期研究

2025-11-010
OA
Short-term clinical outcomes and cost analysis of intracorporeal anastomosis with laparoscopic and robotic staplers during robot-assisted right colon resection: a single-center retrospective study

机器人辅助右半结肠切除术中使用腹腔镜和机器人缝合器进行体内吻合的短期临床结果与成本分析:一项单中心回顾性研究

2025-10-120
PRE
Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal Group

直肠癌手术中回肠造口转移的旋转对小肠梗阻的影响: 大阪大学临床研究组,结直肠组进行的多中心前瞻性研究

SURGERY
IF2.7
2025-02-010
PRE
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
2024-11-020
OAAI
Development of novel rectal/uterine clamping device
2024-10-030
OAAI
Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer

regorafenib在进行性不可切除的转移性结直肠癌中的II期剂量滴定研究

2023-02-096
OAAI